Skip to main content
Clinical Trials/DRKS00016291
DRKS00016291
Not yet recruiting
Not Applicable

ongitudinal change and cardiovascular (CV) impact of blood pressure adjusted pulse wave velocity in patients with advanced chronic kidney disease - no acronym

Charité Universitätsmedizin Berlin Campus Benjamin Franklin Klinik für Nephrologie0 sites400 target enrollmentJanuary 14, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
I70.9
Sponsor
Charité Universitätsmedizin Berlin Campus Benjamin Franklin Klinik für Nephrologie
Enrollment
400
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 14, 2019
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Charité Universitätsmedizin Berlin Campus Benjamin Franklin Klinik für Nephrologie

Eligibility Criteria

Inclusion Criteria

  • Presence of advanced chronic kidney disease (CKD) defined as estimated glomerular filtration rate (eGFR) \<45 ml/min/1,73 m2 according to creatinine\-based CKD\-EPI formula or patients on dialysis
  • At least one valid long\-term BP\-recording and pulse wave analysis (at least 20 hours or at least 38 hours for the study participants on dialysis with at least 70% valid measurements);
  • Subjects willing and able to provide informed consent;
  • Dialysis patients must be at least one year on dialysis;
  • Assumed life expectancy at least one year

Exclusion Criteria

  • Arrhythmias, which make oscillometrical BP\-measurement or pulse wave analysis impossible;
  • Age\<18 years;
  • Stenosis located proximately to or at the measurement point;
  • Myocardial infarction, stroke or invasive CV intervention in the last three months;
  • Subject not able or willing to give informed consent;
  • Hospital stay in last four weeks

Outcomes

Primary Outcomes

Not specified

Similar Trials